Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 50:2357-2368, doi:10.1016/j.jacc.2007.09.021 (Published online 11 December 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.09.021v1
50/25/2357    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daniels, L. B.
Right arrow Articles by Maisel, A. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Daniels, L. B.
Right arrow Articles by Maisel, A. S.

STATE-OF-THE-ART PAPER

Natriuretic Peptides

Lori B. Daniels, MD* and Alan S. Maisel, MD, FACC

Division of Cardiology, University of California at San Diego, and the Division of Cardiology, Veteran's Affairs San Diego Healthcare System, San Diego, California

Manuscript received July 31, 2007; revised manuscript received September 10, 2007, accepted September 26, 2007.

* Reprint requests and correspondence: Dr. Lori B. Daniels, Division of Cardiology, University of California, San Diego, MC 0986, 9350 Campus Point Drive, Suite 1D, La Jolla, California 92037-1300. (Email: loridaniels{at}ucsd.edu).

Natriuretic peptides (NPs) are released from the heart in response to pressure and volume overload. B-type natriuretic peptide (BNP) and N-terminal-proBNP have become important diagnostic tools for assessing patients who present acutely with dyspnea. The NP level reflects a compilation of systolic and diastolic function as well as right ventricular and valvular function. Studies suggest that using NPs in the emergency department can reduce the consumption of hospital resources and can lower costs by either eliminating the need for other, more expensive tests or by establishing an alternative diagnosis that does not require hospital stay. Caveats such as body mass index and renal function must be taken into account when analyzing NP levels. Natriuretic peptide levels have important prognostic value in multiple clinical settings, including in patients with stable coronary artery disease and with acute coronary syndromes. In patients with decompensated heart failure due to volume overload, a treatment-induced drop in wedge pressure is often accompanied by a rapid drop in NP levels. Knowing a patient's NP levels might thus assist with hemodynamic assessment and subsequent treatment titration. Monitoring NP levels in the outpatient setting might also improve patient care and outcomes.

Abbreviations and Acronyms
  AF = atrial fibrillation
  ANP = atrial natriuretic peptide
  AUC = area under the receiver-operating characteristic curve
  BNP = B-type natriuretic peptide
  CAD = coronary artery disease
  CHF = congestive heart failure
  ED = emergency department
  GFR = glomerular filtration rate
  HF = heart failure
  LV = left ventricle/ventricular
  MI = myocardial infarction
  NP = natriuretic peptide
  NPR = natriuretic peptide receptor
  NTproBNP = amino-terminal fragment of B-type natriuretic peptide
  NYHA = New York Heart Association




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. B. Daniels and E. Barrett-Connor
Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1860 - 1861.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
R. K. Rogers, J. Stehlik, G. J. Stoddard, T. Greene, S. P. Collins, W. F. Peacock, A. D. Maisel, P. Clopton, and A. D. Michaels
Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT
Eur J Heart Fail, November 1, 2009; 11(11): 1043 - 1049.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
E. M. Kanoupakis, E. G. Manios, and P. E. Vardas
Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers
Europace, November 1, 2009; 11(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. D. Gottlieb, A. R. Schwartz, J. Marshall, P. Ouyang, L. Kern, V. Shetty, M. Trois, N. M. Punjabi, C. Brown, S. S. Najjar, et al.
Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure.
J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1706 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. C.M. Linssen, S. J.L. Bakker, A. A. Voors, R. T. Gansevoort, H. L. Hillege, P. E. de Jong, D. J. van Veldhuisen, R. O.B. Gans, and D. de Zeeuw
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population
Eur. Heart J., October 23, 2009; (2009) ehp420v1.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Bolliger, M. D. Seeberger, and M. Filipovic
Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet?
J. Am. Coll. Cardiol., October 20, 2009; 54(17): 1607 - 1608.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
P. A. Scott, J. Barry, P. R. Roberts, and J. M. Morgan
Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis
Eur J Heart Fail, October 1, 2009; 11(10): 958 - 966.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J-C Lega, Y Lacasse, L Lakhal, and S Provencher
Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis
Thorax, October 1, 2009; 64(10): 869 - 875.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B Dieplinger, A Gegenhuber, M Haltmayer, and T Mueller
Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath
Heart, September 15, 2009; 95(18): 1508 - 1513.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
S. M. Dunlay, Y. Gerber, S. A. Weston, J. M. Killian, M. M. Redfield, and V. L. Roger
Prognostic Value of Biomarkers in Heart Failure: Application of Novel Methods in the Community
Circ Heart Fail, September 1, 2009; 2(5): 393 - 400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Casals, J. Ros, A. Sionis, M. M. Davidson, M. Morales-Ruiz, and W. Jimenez
Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H550 - H555.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Gao, C.-L. Long, R.-H. Wang, and H. Wang
KATP activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function
Cardiovasc Res, August 1, 2009; 83(3): 444 - 456.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. C.M. Linssen, K. Damman, H. L. Hillege, G. Navis, D. J. van Veldhuisen, and A. A. Voors
Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure
Circulation, July 7, 2009; 120(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
R. V. Shah, A. A. Chen-Tournoux, M. H. Picard, R. R.J. van Kimmenade, and J. L. Januzzi
Serum Levels of the Interleukin-1 Receptor Family Member ST2, Cardiac Structure and Function, and Long-Term Mortality in Patients With Acute Dyspnea
Circ Heart Fail, July 1, 2009; 2(4): 311 - 319.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Cohen-Solal, D. Logeart, B. Huang, D. Cai, M. S. Nieminen, and A. Mebazaa
Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart Failure
J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2343 - 2348.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Gheorghiade and P. S. Pang
Are BNP Changes During Hospitalization for Heart Failure a Reliable Surrogate for Predicting the Effects of Therapies on Post-Discharge Mortality?
J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2349 - 2352.
[Full Text] [PDF]


Home page
CirculationHome page
S. S. Chugh and K. Reinier
Predicting Sudden Death in the General Population: Another Step, N Terminal B-Type Natriuretic Factor Levels
Circulation, June 9, 2009; 119(22): 2863 - 2864.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S Dhar, G S Pressman, S Subramanian, S Kaul, S Gollamudi, E J Bloom, and V M Figueredo
Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence
Postgrad. Med. J., June 1, 2009; 85(1004): 299 - 302.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Vassalle and M. G. Andreassi
Genetic Polymorphisms of the Natriuretic Peptide System in the Pathogenesis of Cardiovascular Disease: What Lies on the Horizon?
Clin. Chem., May 1, 2009; 55(5): 878 - 887.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. Bolliger, M. D. Seeberger, G. A. L. Lurati Buse, P. Christen, B. Rupinski, L. Gurke, and M. Filipovic
A Preliminary Report on the Prognostic Significance of Preoperative Brain Natriuretic Peptide and Postoperative Cardiac Troponin in Patients Undergoing Major Vascular Surgery
Anesth. Analg., April 1, 2009; 108(4): 1069 - 1075.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Bernus, B. D. Wagner, F. Accurso, A. Doran, H. Kaess, and D. D. Ivy
Brain Natriuretic Peptide Levels in Managing Pediatric Patients With Pulmonary Arterial Hypertension
Chest, March 1, 2009; 135(3): 745 - 751.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. G. Semenov, A. B. Postnikov, N. N. Tamm, K. R. Seferian, N. S. Karpova, M. N. Bloshchitsyna, E. V. Koshkina, M. I. Krasnoselsky, D. V. Serebryanaya, and A. G. Katrukha
Processing of Pro-Brain Natriuretic Peptide Is Suppressed by O-Glycosylation in the Region Close to the Cleavage Site
Clin. Chem., March 1, 2009; 55(3): 489 - 498.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
R. W. Troughton and A. M. Richards
B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.
J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 216 - 225.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Kruger, S. Kotter, A. Grutzner, P. Lang, C. Andresen, M. M. Redfield, E. Butt, C. G. dos Remedios, and W. A. Linke
Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin Springs
Circ. Res., January 2, 2009; 104(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Andreassen, I. Raymond, C. Kistorp, P. Hildebrandt, J. Faber, and L. O. Kristensen
IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population
Eur. J. Endocrinol., January 1, 2009; 160(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner
CHAPTER 23 Heart Failure
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Senggunprai, K. Yoshinari, M. Shimada, and Y. Yamazoe
Involvement of ST1B Subfamily of Cytosolic Sulfotransferase in Kynurenine Metabolism to Form Natriuretic Xanthurenic Acid Sulfate
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 789 - 798.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. Vila, M. Resl, D. Stelzeneder, J. Struck, C. Maier, M. Riedl, M. Hulsmann, R. Pacher, A. Luger, and M. Clodi
Plasma NT-proBNP increases in response to LPS administration in healthy men
J Appl Physiol, December 1, 2008; 105(6): 1741 - 1745.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. Tagore, L. H. Ling, H. Yang, H.-Y. Daw, Y.-H. Chan, and S. K. Sethi
Natriuretic Peptides in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1644 - 1651.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Lippi, G. Targher, and S. Z. Goldhaber
Natriuretic Peptides for Assessing the Prognosis of Acute Pulmonary Embolism
Chest, June 1, 2008; 133(6): 1531 - 1532.
[Full Text] [PDF]


Home page
NEJMHome page
E. Braunwald
Biomarkers in Heart Failure
N. Engl. J. Med., May 15, 2008; 358(20): 2148 - 2159.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement